Evaluate the Migration Potential of Xeomin® Compared to Two Other Botulinum Toxin Type A Products
Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
Xeomin® is a Botulinum neurotoxin type A preparation free of complexing proteins, i.e. free
of bacterial proteins other than the active toxin. Injected into the muscle, Xeomin® causes
local weakening. Botulinum toxin type A is used for certain neurological and aesthetic
treatments. This study will investigate the migration potential of Xeomin®.
Phase:
Phase 1
Details
Lead Sponsor:
Merz Pharmaceuticals GmbH
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA